| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CMO | Chief Medical Officer
2 companies
Joanne M. Donovan is CMO at EWTX, with reported holdings spanning 2 companies. From June 2015 to August 2026, the filings on record show 0 open-market purchases and 11 sales. Joanne M. Donovan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $325K at current prices.
Our model assigns Joanne M. Donovan a below-average insider score of 49/100, based on 11 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -37.0%.
Joanne M. Donovan's largest disclosed position is in EWTX as CMO, worth about $325K. The EWTX filings lean toward selling, a net 178,176 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 3,254 | $8.90 | $28,976.54 | -24.6% | -16.7% | +117.3% |